BX Swiss TOP 30 CHF
1.376,73
PKT
-7,97
PKT
-0,58
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 17.04.19 | Roche buy | Goldman Sachs Group Inc. | |
| 17.04.19 | Novartis buy | Jefferies & Company Inc. | |
| 17.04.19 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 17.04.19 | Swiss Re Sector Perform | RBC Capital Markets | |
| 16.04.19 | Novartis buy | Kepler Cheuvreux | |
| 16.04.19 | Swiss Re overweight | JP Morgan Chase & Co. | |
| 12.04.19 | Zurich Insurance Neutral | JP Morgan Chase & Co. | |
| 12.04.19 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 12.04.19 | ABB (Asea Brown Boveri) buy | Deutsche Bank AG | |
| 12.04.19 | Holcim overweight | JP Morgan Chase & Co. | |
| 12.04.19 | Holcim Neutral | Goldman Sachs Group Inc. | |
| 11.04.19 | Nestlé overweight | Morgan Stanley | |
| 11.04.19 | Givaudan Neutral | UBS AG | |
| 11.04.19 | Holcim Sell | UBS AG | |
| 11.04.19 | UBS buy | Deutsche Bank AG | |
| 11.04.19 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 11.04.19 | Roche buy | Goldman Sachs Group Inc. | |
| 10.04.19 | Givaudan Hold | Kepler Cheuvreux | |
| 10.04.19 | Alcon Neutral | UBS AG | |
| 10.04.19 | Novartis Underweight | Barclays Capital | |
| 10.04.19 | Nestlé overweight | Barclays Capital | |
| 10.04.19 | Novartis Underweight | Morgan Stanley | |
| 09.04.19 | Givaudan Sell | Goldman Sachs Group Inc. | |
| 09.04.19 | UBS Neutral | JP Morgan Chase & Co. | |
| 09.04.19 | UBS overweight | JP Morgan Chase & Co. | |
| 09.04.19 | Givaudan Underperform | Bernstein Research | |
| 09.04.19 | Givaudan Sell | Goldman Sachs Group Inc. | |
| 09.04.19 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 08.04.19 | Holcim buy | Deutsche Bank AG | |
| 08.04.19 | UBS buy | UBS AG | |
| 08.04.19 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 08.04.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 08.04.19 | Swiss Re overweight | JP Morgan Chase & Co. | |
| 08.04.19 | Novartis Underweight | Barclays Capital | |
| 05.04.19 | Novartis Neutral | Credit Suisse Group | |
| 05.04.19 | UBS overweight | Morgan Stanley | |
| 05.04.19 | UBS Equal-Weight | Morgan Stanley | |
| 05.04.19 | Nestlé buy | Merrill Lynch & Co., Inc. | |
| 05.04.19 | Roche Hold | Deutsche Bank AG | |
| 05.04.19 | Novartis Hold | Deutsche Bank AG |